Clinical Trial: ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07505849) titled 'ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma' on March 24.

Brief Summary: Primary Objective: To compare the complete response rate (CR rate) after induction treatment between the ZR2 regimen and the R2 regimen.Secondary Objectives: To compare the objective response rate (ORR) after induction treatment, progression-free survival (PFS), progression of disease within 24 months (POD24) rate, duration of response (DOR), overall survival (OS), treatment-related adverse events (AEs), and patient quality of life between the two groups.Exploratory Objectives: To compare the histological .transformation (HT) r...